In general, infection with YFV_NS3/NS5_2010 virus in cellular models displayed an intermediate phenotype compared to YFV_NS5_2010 and YFV_2017, suggesting that NS3-2010 variants somehow modulate the NS5-2010 effect in the mammal infection capacity. This evidence concerns the gene KRAS and infection.